AbCellera Biologics Inc. (ABCL) Revenue 2019–2025
AbCellera Biologics Inc. (ABCL) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$75.1MFY2025 · since FY2019: $11.6M → $75.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.1M | +160.6% |
| FY2024 | $28.8M | -24.2% |
| FY2023 | $38.0M | -92.2% |
| FY2022 | $485.4M | +29.4% |
| FY2021 | $375.2M | +60.9% |
| FY2020 | $233.2M | +1907.9% |
| FY2019 | $11.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice